Analysis of different U.S. stocks that landed on the green zone, according to the course of Tuesday`s trade:
According to the market data Metabolix, Inc. (NASDAQ:MBLX) shares climbed 56.72% and closed at $1.05 on the last trading session. According to the filed paper at the stock exchange, Metabolix, Inc. a Bioscience Corporation, focuses on delivering sustainable solutions to the plastics and chemicals industries.
In a recent statement they also declared that, they had reached a global agreement with Honeywell to offer new marine biodegradable biopolymers which can be used in cosmetics and personal care products.
Springleaf Holdings Inc. (NYSE:LEAF) reached a new high in 52-weeks when their shares reached $52.48. The company raised 32.05% and closed at $50.23. Springleaf is a personal financial corporation which provides loans to consumers. In a recent statement they said, they have reached an agreement with CitiFinancial Credit Corporation, a wholly-owned partner of Citigroup (NYSE:C) to attain OneMain financial. They have paid $4.25 billion to attain the company. It was reported that the joined corporation is expected to have 1,967 branches across 43 states.
According to market reports, analysts from five brokerage firms have agreed to estimate the price target of about $10.6 for obesity drug maker . The reports also suggested that the stock prices could change by $3 (approx.) over medium term. The highest estimation for price target is $16 with a mean of $10.6.
It was earlier reported that, Orexigen’s partner for North America, Takeda Pharmaceuticals, had launched Contrave in the United States on October 20, 2014. U.S. It was also reported that net sales for Takeda in the fourth quarter were $6.5 million. Orexigen will receive $1.3 million in royalties.
Ceres Inc. (NASDAQ:CERE) shares rose 33.33% and closed at $0.460. In a statement on 26th February Ceres declared that they have achieved gold partnership with Oracle PartnerNetwork. The Gold Membership suggested that, Ceres committed to use Oracle-related knowledge in delivering Ceres’ Persephone genome visualization software and for exclusively addressing the challenges of joint customers.
